Heron Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.85

-0.06 (-6.84%)

As of May 16, 2:04 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,583.5% upside

Low Target $15.42

Average Target $22.81

High Target $25.92

Current Price $0.85

Current
$0.85

Target
$22.81

$15.42 $22.81 avg $25.92

Scenario Analysis

Bear Case

$15.42

1,714.1%

Low target

Base Case

$22.81

+2,583.5%

Avg target

Bull Case

$25.92

+2,949.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.30

-63.0% from high

52-Week Low

$0.74

+15.5% from low

Target vs 52W High

$22.81

+891.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%